c-Rel Arrests the Proliferation of HeLa Cells and Affects Critical Regulators of the G₁/S-Phase Transition

REFERENCES

• Abbadie, C., N. Kabrun, F. Bouali, J. Smardova, D. Stéhelin, B. Vandenbunder, and P. J. Enrietto. 1993. High levels of c-rel expression are associated with programmed cell death in the developing avian embryo and in bone marrow cells in vitro. Cell 75:899–912.
   PubMed Web of Science ®Google Scholar
• Adams, P. D., and W. G. Kaelin, Jr. 1996. The cellular effects of E2F overexpression. Curr. Top. Microbiol. Immunol. 208:79–93.
   PubMedGoogle Scholar
• Avantaggiati, M. L., V. Ogryzko, K. Gardner, A. Giordano, A. S. Levine, and K. Kelly. 1997. Recruitment of p300/CBP in p53-dependent signal pathways. Cell 89:1175–1184.
   PubMed Web of Science ®Google Scholar
• Baeuerle, P., and T. Henkel. 1994. Function and activation of NF-kB in the immune system. Annu. Rev. Immunol. 12:141–179.
   PubMed Web of Science ®Google Scholar
• Baldwin, A. S., Jr. 1996. The NF-kB and IkB proteins: new discoveries and insights. Annu. Rev. Immunol. 14:649–681.
   PubMed Web of Science ®Google Scholar
• Baldwin, A. S., Jr., J. C. Azizkhan, D. E. Jensen, A. A. Beg, and L. R. Coodly. 1991. Induction of NF-kB DNA-binding activity during the G0-to-G1 transition in mouse fibroblasts. Mol. Cell. Biol. 11:4943–4951.
   PubMed Web of Science ®Google Scholar
• Barnes, P. J., and M. Karin. 1997. Nuclear factor-kB—a pivotal transcription factor in chronic inflammatory diseases. N. Engl. J. Med. 336:1066–1071.
   PubMed Web of Science ®Google Scholar
• Beg, A. A., and D. Baltimore. 1996. An essential role for NF-kB in preventing TNF-a-induced cell death. Science 274:782–784.
   PubMed Web of Science ®Google Scholar
• Beg, A. A., W. C. Sha, R. T. Bronson, S. Ghosh, and D. Baltimore. 1995. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. Nature 376:167–170.
   PubMed Web of Science ®Google Scholar
• Bernard, H. U., G. Krammer, and W. G. Rowekamp. 1985. Construction of a fusion gene that confers resistance against hygromycin B to mammalian cells in culture. Exp. Cell Res. 158:237–243.
   PubMedGoogle Scholar
• Boothby, M. R., A. L. Mora, D. C. Scherer, J. A. Brockman, and D. W. Ballard. 1997. Perturbation of the T lymphocyte lineage in transgenic mice expressing a constitutive repressor of nuclear factor (NF)-kB. J. Exp. Med. 185:1897–1907.
   PubMed Web of Science ®Google Scholar
• Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248–254.
   PubMed Web of Science ®Google Scholar
• Brown, K., S. Park, T. Kanno, G. Franzoso, and U. Siebenlist. 1993. Mutual regulation of the transcriptional activator NF-kappa B and its inhibitor, I kappa B-alpha. Proc. Natl. Acad. Sci. USA 90:2532–2536.
   PubMed Web of Science ®Google Scholar
• Brownell, E., B. Mathieson, H. A. Young, J. Keller, J. N. Ihle, and N. R. Rice. 1987. Detection of c-rel-related transcripts in mouse hematopoietic tissues, fractionated lymphocyte populations, and cell lines. Mol. Cell. Biol. 7:1304–1309.
   PubMedGoogle Scholar
• Brownell, E., F. W. Ruscetti, R. G. Smith, and N. R. Rice. 1988. Detection of rel-related RNA and protein in human lymphoid cells. Oncogene 3:93–98.
   Google Scholar
• Burnette, W. N. 1981. “Western blotting”: electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal. Biochem. 112:195–203.
   PubMed Web of Science ®Google Scholar
• Capobianco, A. J., D. L. Simmons, and T. D. Gilmore. 1990. Cloning and expression of a chicken c-rel cDNA: unlike p59v-rel, p68c-rel is a cytoplasmic protein in chicken embryo fibroblasts. Oncogene 5:257–265.
   PubMedGoogle Scholar
• Carrasco, D., F. Weih, and R. Bravo. 1994. Developmental expression of the mouse c-rel proto-oncogene in hematopoietic organs. Development 120:2991–3004.
   PubMedGoogle Scholar
• Chen, C. and H. Okayama. 1987. High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7:2745–2752.
   PubMed Web of Science ®Google Scholar
• Chen, P. L., D. J. Riley, and W. H. Lee. 1995. The retinoblastoma protein as a fundamental mediator of growth and differentiation signals. Crit. Rev. Eukaryotic Gene Expr. 5:79–95.
   PubMedGoogle Scholar
• Chiou, S. K., C. C. Tseng, L. Rao, and E. White. 1994. Functional complementation of the adenovirus E1B 19-kilodalton protein with Bcl-2 in the inhibition of apoptosis in infected cells. J. Virol. 68:6553–6566.
   PubMedGoogle Scholar
• Chowdary, D. R., J. J. Dermody, K. K. Jha, and H. L. Ozer. 1994. Accumulation of p53 in a mutant cell line defective in the ubiquitin pathway. Mol. Cell. Biol. 14:1997–2003.
   PubMed Web of Science ®Google Scholar
• Darzynkiewicz, Z., S. Bruno, G. Del Bino, W. Gorczyca, M. A. Hotz, P. Lassota, and F. Traganos. 1992. Features of apoptotic cells measured by flow cytometry. Cytometry 13:795–808.
   PubMedGoogle Scholar
• Di Leonardo, A., S. P. Linke, K. Clarkin, and G. M. Wahl. 1994. DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts. Genes Dev. 8:2540–2551.
   PubMed Web of Science ®Google Scholar
• Dulic, V., W. K. Kaufmann, S. J. Wilson, T. D. Tlsty, E. Lees, J. W. Harper, S. J. Elledge, and S. I. Reed. 1994. p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell 76:1013–1023.
   PubMed Web of Science ®Google Scholar
• Eck, S. L., N. D. Perkins, D. P. Carr, and G. J. Nabel. 1993. Inhibition of phorbol ester-induced cellular adhesion by competitive binding of NF-kB in vivo. Mol. Cell. Biol. 13:6530–6536.
   PubMedGoogle Scholar
• El-Deiry, W. S., J. W. Harper, P. M. O’Connor, V. E. Velculescu, C. E. Canman, J. Jackman, J. A. Pietenpol, M. Burrell, D. E. Hill, and Y. Wang. 1994. WAF1/C1P1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res. 54:1169–1174.
   PubMed Web of Science ®Google Scholar
• El-Deiry, W. S., T. Tokino, V. E. Velculescu, D. B. Levy, R. Parson, J. M. Trent, D. Lin, W. E. Mercer, K. W. Kinzler, and B. Vogelstein. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75:817–825.
   PubMed Web of Science ®Google Scholar
• Elledge, S. J., and J. W. Harper. 1994. Cdk inhibitors: on the threshold of checkpoints and development. Curr. Opin. Cell Biol. 6:847–852.
   PubMed Web of Science ®Google Scholar
• Ellis, R. E., J. Y. Yuan, and H. R. Horvit. 1991. Mechanisms and functions of cell death. Annu. Rev. Cell Biol. 7:663–698.
   PubMed Web of Science ®Google Scholar
• Gilmore, T. D., M. Koedood, K. A. Piffat, and D. W. White. 1996. Rel/NF-kB/IkB proteins and cancer. Oncogene 13:1367–1378.
   PubMed Web of Science ®Google Scholar
• Gilmore, T. D., and H. M. Temin. 1986. Different localization of the product of the v-rel oncogene in chicken fibroblasts and spleen cells correlates with transformation by Rev-T. Cell 44:791–800.
   PubMed Web of Science ®Google Scholar
• Gilmore, T. D., and H. M. Temin. 1988. v-rel oncoproteins in the nucleus and in the cytoplasm transform chicken spleen cells. J. Virol. 62:703–714.
   PubMedGoogle Scholar
• Gossen, M., and H. Bujard. 1992. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. USA 89:5541–5557.
   Google Scholar
• Griffin, G. E., K. Leung, T. M. Folks, S. Kunkel, and G. J. Nabel. 1989. Activation of HIV gene expression during monocyte differentiation by induction of NF-kappa B. Nature 339:70–73.
   PubMed Web of Science ®Google Scholar
• Grilli, M., J. J.-S. Chiu, and M. J. Lenardo. 1993. NF-kB and Rel: participants in a multiform transcriptional regulatory system. Int. Rev. Cytol. 143:1–62.
   PubMed Web of Science ®Google Scholar
• Grimm, S., M. K. A. Bauer, P. A. Baeuerle, and K. Schulze-Osthoff. 1996. Bcl-2 down-regulates the activity of transcription factor NF-kB induced upon apoptosis. J. Cell Biol. 134:13–23.
   PubMed Web of Science ®Google Scholar
• Gu, W., X.-L. Shi, and R. G. Roeder. 1997. Synergistic activation of transcription by CBP and p53. Nature 387:819–823.
   PubMed Web of Science ®Google Scholar
• Haupt, Y., S. Rowan, and M. Oren. 1995. p53-mediated apoptosis can be overcome by excess pRB. Oncogene 10:1563–1571.
   PubMed Web of Science ®Google Scholar
• Herzog, N. K., W. J. Bargmann, and H. R. Bose. 1986. Oncogene expression in reticuloendotheliosis virus-transformed lymphoid cell lines and avian tissues. J. Virol. 57:371–375.
   PubMedGoogle Scholar
• Hinds, P. W., C. A. Finlay, A. B. Frey, and A. J. Levine. 1987. Immunological evidence for the association of p53 with a heat shock protein, hsc70, in p53-plus-ras-transformed cell lines. Mol. Cell. Biol. 7:2863–2869.
   PubMed Web of Science ®Google Scholar
• Hoffman, B., and D. A. Liebermann. 1994. Molecular controls of apoptosis: differentiation/growth arrest primary response genes, proto-oncogenes, and tumor suppressor genes as positive & negative modulators. Oncogene 9:1807–1812.
   PubMed Web of Science ®Google Scholar
• Hunter, T., and J. Pines. 1994. Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age. Cell 79:573–582.
   PubMed Web of Science ®Google Scholar
• Hwang, E.-S., L. K. Naeger, and D. DiMaio. 1996. Activation of the endogenous p53 growth inhibitory pathway in HeLa cervical carcinoma cells by expression of the bovine papillomavirus E2 gene. Oncogene 12:795–803.
   PubMedGoogle Scholar
• Inuzuka, M., H. Ishikawa, S. Kumar, C. Gélinas, and Y. Ito. 1994. The viral and cellular Rel oncoproteins induce the differentiation of P19 embryonal carcinoma cells. Oncogene 9:133–140.
   PubMedGoogle Scholar
• Jiang, H., J. Lin, Z. Z. Su, F. R. Collart, E. Huberman, and P. B. Fisher. 1994. Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/C1P1, expression in the absence of p53. Oncogene 9:3397–3406.
   PubMed Web of Science ®Google Scholar
• Kaelin, W. G., Jr., D. C. Pallas, J. A. DeCaprio, F. J. Kaye, and D. M. Livingston. 1991. Identification of cellular proteins that can interact specifically with the T/E1A-binding region of the retinoblastoma gene product. Cell 64:521–532.
   PubMed Web of Science ®Google Scholar
• Ko, L. J., and C. Prives. 1996. p53: puzzle and paradigm. Genes Dev. 10:1054–1072.
   PubMed Web of Science ®Google Scholar
• Kranenburg, O., R. P. de Grott, A. J. Van der Eb, and A. Zantema. 1995. Differentiation of P19 EC cells leads to differential modulation of cyclin-dependent kinase activities and to changes in the cell cycle profile. Oncogene 10:87–95.
   PubMedGoogle Scholar
• Kumar, S., and C. Gélinas. 1993. IkBa-mediated inhibition of v-Rel DNA binding requires direct interaction with the RxxRxRxxC Rel/kB DNA-bind-ing motif. Proc. Natl. Acad. Sci. USA 90:8962–8966.
   PubMedGoogle Scholar
• Le Bail, O., R. Schmidt-Ullrich, and A. Israel. 1993. Promoter analysis of the gene encoding the I kappa B-alpha/MAD3 inhibitor of NF-kappa B: positive regulation by members of the rel/NF-kappa B family. EMBO J. 12:5043–5049.
   PubMed Web of Science ®Google Scholar
• Lee, H., M. Arsura, M. Wu, M. Duyao, A. J. Buckler, and G. E. Sonenshein. 1995. Role of Rel-related factors in control of c-myc gene transcription in receptor-mediated apoptosis of the murine B cell WEHI 231 line. J. Exp. Med. 181:1169–1177.
   PubMed Web of Science ®Google Scholar
• Liebermann, D. A., B. Hoffman, and R. A. Steinman. 1995. Molecular controls of growth arrest and apoptosis: p53-dependent and independent pathways. Oncogene 11:199–210.
   PubMed Web of Science ®Google Scholar
• Lill, N. L., S. R. Grossman, D. Ginsberg, J. DeCaprio, and D. M. Livingston. 1997. Binding and modulation of p53 by p300/CBP coactivators. Nature 387:823–827.
   PubMed Web of Science ®Google Scholar
• Liou, H. C., W. C. Sha, M. L. Scott, and D. Baltimore. 1994. Sequential induction of NF-kB/Rel family proteins during B-cell terminal differentiation. Mol. Cell. Biol. 14:5349–5359.
   PubMed Web of Science ®Google Scholar
• Liu, Z.-G., H. Hsu, D. V. Goeddel, and M. Karin. 1996. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kB activation prevents cell death. Cell 87:565–576.
   PubMed Web of Science ®Google Scholar
• Luque, I., and C. Gélinas. 1997. Rel/NF-kB and IkB factors in oncogenesis. Semin. Cancer Biol. 8:103–111.
   PubMed Web of Science ®Google Scholar
• Maki, C. G., J. M. Huibregtse, and P. M. Howley. 1996. In vivo ubiquitina-tion and proteasome-mediated degradation of p53(1). Cancer Res. 56:2649–2654.
   PubMed Web of Science ®Google Scholar
• Matlashewski, G., L. Banks, D. Pim, and L. Crawford. 1986. Analysis of human p53 proteins and mRNA levels in normal and transformed cells. Eur. J. Biochem. 154:665–672.
   PubMedGoogle Scholar
• May, E., J. R. Jenkins, and P. May. 1991. Endogenous HeLa p53 proteins are easily detected in HeLa cells transfected with mouse deletion mutant p53 gene. Oncogene 6:1363–1365.
   PubMed Web of Science ®Google Scholar
• Michieli, P., M. Chedid, D. Lin, J. H. Pierce, W. E. Mercer, and D. Givol. 1994. Induction of WAF1/C1P1 by a p53-independent pathway. Cancer Res. 54:3391–3395.
   PubMed Web of Science ®Google Scholar
• Miyamoto, S., and I. M. Verma. 1995. Rel/NF-kB/IkB story. Adv. Cancer Res. 66:255–293.
   PubMed Web of Science ®Google Scholar
• Moore, B. E., and H. R. Bose. 1989. Expression of the c-rel and c-myc proto-oncogenes in avian tissues. Oncogene 4:845–852.
   PubMed Web of Science ®Google Scholar
• Morgan, D. O. 1995. Principles of CDK regulation. Nature 374:131–134.
   PubMed Web of Science ®Google Scholar
• Neiman, P. E., S. J. Thomas, and G. Loring. 1991. Induction of apoptosis during normal and neoplastic B-cell development in the bursa of Fabricius. Proc. Natl. Acad. Sci. USA 88:5857–5861.
   PubMedGoogle Scholar
• Nolan, G. P., and D. Baltimore. 1992. The inhibitory ankyrin and activator Rel proteins. Curr. Opin. Genet. Dev. 2:211–220.
   PubMed Web of Science ®Google Scholar
• Olashaw, N. E., T. F. Kowalik, E.-S. Huang, and W. J. Pledger. 1992. Induction of NF-kB-like activity by platelet-derived growth factor in mouse fibroblasts. Mol. Biol. Cell 3:1131–1139.
   PubMedGoogle Scholar
• Pagano, M., S. W. Tam, A. M. Theodaras, P. Beer-Romero, G. Del Sal, V. Chau, P. R. Yew, G. F. Draetta, and M. Rolfe. 1995. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 269:682–685.
   PubMed Web of Science ®Google Scholar
• Perkins, N. D., L. K. Felzien, J. C. Betts, K. Leung, D. H. Beach, and G. J. Nabel. 1997. Regulation of NF-kB by cyclin-dependent kinases associated with the p300 coactivator. Science 275:523–527.
   PubMed Web of Science ®Google Scholar
• Resnitzky, D., M. Gossen, H. Bujard, and S. I. Reed. 1994. Acceleration of the G1/S-phase transition by expression of cyclins D1 and E with an inducible system. Mol. Cell. Biol. 14:1669–1679.
   PubMed Web of Science ®Google Scholar
• Sangfelt, O., S. Erickson, S. Einhorn, and D. Grandér. 1997. Induction of Cip/Kip and Ink4 cyclin dependent kinase inhibitors by interferon-alpha in hematopoietic cell lines. Oncogene 14:415–423.
   PubMed Web of Science ®Google Scholar
• Sarnow, P., Y. S. Ho, J. Williams, and A. J. Levine. 1982. Adenovirus E1b-58kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54kd cellular protein in transformed cells. Cell 28:387–394.
   PubMed Web of Science ®Google Scholar
• Schatzle, J. D., J. Kralova, and H. R. Bose, Jr. 1995. Avian IkBa is transcriptionally induced by c-Rel and v-Rel with different kinetics. J. Virol. 69:5383–5390.
   PubMedGoogle Scholar
• Scheffner, M., J. M. Huibregtse, R. D. Vierstra, and P. M. Howley. 1993. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 75:495–505.
   PubMed Web of Science ®Google Scholar
• Scheffner, M., K. Munger, J. C. Byrne, and P. M. Howley. 1991. The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines. Proc. Natl. Acad. Sci. USA 88:5523–5527.
   PubMed Web of Science ®Google Scholar
• Sheikh, M. S., Y. Q. Chen, M. L. Smith, and A. J. Fornace, Jr. 1997. Role of p21Waf1/Cip1/Sdi1 in cell death and DNA repair as studied using a tetracycline-inducible system in p53-deficient cells. Oncogene 14:1875–1882.
   PubMedGoogle Scholar
• Sherr, C. J. 1994. G1 phase progression: cycling on cue. Cell 79:551–555.
   PubMed Web of Science ®Google Scholar
• Sherr, C. J., and J. M. Roberts. 1995. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9:1149–1163.
   PubMed Web of Science ®Google Scholar
• Siebenlist, U., G. Franzoso, and K. Brown. 1994. Structure, regulation and function of NF-kB. Annu. Rev. Cell Biol. 10:405–455.
   PubMedGoogle Scholar
• Somasundaram, K., and W. S. El-Deiry. 1997. Inhibition of p53-mediated transactivation and cell cycle arrest by E1A through its p300/CBP-interacting region. Oncogene 14:1047–1057.
   PubMed Web of Science ®Google Scholar
• Steinman, R. A., B. Hoffman, A. Iro, C. Guillouf, D. A. Libermann, and M. E. el-Houseini. 1994. Induction of p21 (WAF-1/C1P1) during differentiation. Oncogene 9:3389–3396.
   PubMed Web of Science ®Google Scholar
• Thanos, D., and T. Maniatis. 1995. NF-kB: a lesson in family values. Cell 80:529–532.
   PubMed Web of Science ®Google Scholar
• Van Antwerp, D. J., S. J. Martin, T. Kafri, D. R. Green, and I. M. Verma. 1996. Suppression of TNF-a-induced apoptosis by NF-kB. Science 274:787–789.
   PubMed Web of Science ®Google Scholar
• Verma, I. M., J. K. Stevenson, E. M. Schwarz, D. Van Antwerp, and S. Miyamoto. 1995. Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation. Genes Dev. 9:2723–2735.
   PubMed Web of Science ®Google Scholar
• Wang, C.-Y., M. W. Mayo, and A. S. Baldwin, Jr. 1996. TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kB. Science 274:784–787.
   PubMed Web of Science ®Google Scholar
• Weinberg, R. A. 1995. The retinoblastoma protein and cell cycle control. Cell 81:323–330.
   PubMed Web of Science ®Google Scholar
• White, D. W., A. Roy, and T. D. Gilmore. 1995. The v-Rel oncoprotein blocks apoptosis and proteolysis of IkB-α in transformed chicken spleen cells. Oncogene 10:857–868.
   PubMedGoogle Scholar
• White, E. 1996. Life, death, and the pursuit of apoptosis. Genes Dev. 10:1–15.
   PubMed Web of Science ®Google Scholar
• Wright, K. L., L. C. White, A. Kelly, S. Beck, J. Trowsdale, and J. P.-Y. Ting. 1995. Coordinate regulation of the human TAP1 and LMP2 genes from a shared bidirectional promoter. J. Exp. Med. 181:1459–1471.
   PubMed Web of Science ®Google Scholar
• Wu, H., and G. Lozano. 1994. NF-kappa B activation of p53. A potential mechanism for suppressing cell growth in response to stress. J. Biol. Chem. 269:20067–20074.
   PubMed Web of Science ®Google Scholar
• Wu, M., H. Lee, R. E. Bellas, S. L. Schauer, M. Arsura, D. Katz, M. J. FitzGerald, T. L. Rothstein, D. H. Sherr, and G. E. Sonenshein. 1996. Inhibition of NF-kB/Rel induces apoptosis of murine B cells. EMBO J. 15:4682–4690.
   PubMed Web of Science ®Google Scholar
• Xiong, Y., D. Kuppuswamy, Y. Li, E. M. Livanos, M. Hixon, A. White, D. Beach, and T. D. Tlsty. 1996. Alteration of cell cycle kinase complexes in human papillomavirus E6- and E7-expressing fibroblasts precedes neoplastic transformation. J. Virol. 70:999–1008.
   PubMed Web of Science ®Google Scholar
• Zhang, W., L. Grasso, C. D. McClain, A. M. Gambel, Y. Cha, S. Travali, A. B. Deisseroth, and W. E. Mercer. 1995. p53-independent induction of WAF1/ C1P1 in human leukemia cells is correlated with growth arrest accompanying monocyte/macrophage differentiation. Cancer Res. 55:668–674.
   PubMed Web of Science ®Google Scholar
• Zong, W.-X., J. Bash, and C. Gélinas. Submitted for publication.
   Google Scholar
• Zong, W.-X., M. Farrell, J. Bash, and C. Gélinas. 1997. v-Rel prevents apoptosis in transformed lymphoid cells and blocks TNFa-induced cell death. Oncogene 15:971–980.
   PubMedGoogle Scholar